Literature DB >> 30448220

Spindle assembly checkpoint MAD2 and CDC20 overexpressions and cell-in-cell formation in gastric cancer and its precursor lesions.

Younghye Kim1, Jung-Woo Choi1, Ju-Han Lee1, Young-Sik Kim2.   

Abstract

Overexpression of mitotic arrest deficient 2 (MAD2) and/or cell division cycle 20 (CDC20) in the spindle assembly checkpoint leads to chromosomal instability and aneuploidy. Cell-in-cell (CIC) structures are formed by the process where cancer or immune cells are internalized into adjacent host cancer cells. Here, we investigated the clinicopathological significances of spindle assembly checkpoint protein overexpression and CIC structures in 829 cases of normal, premalignant, and gastric cancer (GC) lesions. MAD2 and CDC20 expressions were significantly increased in intestinal metaplasia, low-grade dysplasia, high-grade dysplasia (HGD), and early GC than normal mucosa, and their expression levels were the highest in HGD. Interestingly, CDC20 immunohistochemistry specifically stained the outer cells of CIC structures, which were the most frequently observed in early GC. In univariate analyses, MAD2 and CDC20 overexpressions and CIC formation were associated with older age, intestinal histology, lower tumor-node-metastasis stage, and longer recurrence-free survival and cancer-specific survival of GC patients. In multivariate survival analyses, MAD2 and CDC20 overexpressions were associated with better recurrence-free survival (hazard ratio, 0.61; P = .012) and cancer-specific survival (hazard ratio, 0.63; P = .043), respectively. In conclusion, MAD2 and CDC20 are the most expressed in HGD, suggesting their roles in the early stage of gastric carcinogenesis, whereas their overexpressions in GC are associated with intestinal histology and favorable clinicopathological parameters, which may be useful for immunohistochemical classification of chromosomal instability-type GC. Moreover, CDC20 is a novel immunohistochemical marker for highlighting CIC structures.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aneuploidy; CDC20; Cell-in-cell structure; Gastric cancer; MAD2

Mesh:

Substances:

Year:  2018        PMID: 30448220     DOI: 10.1016/j.humpath.2018.10.029

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  14 in total

1.  miR-139-5p Inhibits Lung Adenocarcinoma Cell Proliferation, Migration, and Invasion by Targeting MAD2L1.

Authors:  Jianfeng Li; Xi He; Xiaotang Wu; Xiaohui Liu; Yixiong Huang; Yuchen Gong
Journal:  Comput Math Methods Med       Date:  2020-11-04       Impact factor: 2.238

2.  CDC20 promotes the progression of hepatocellular carcinoma by regulating epithelial‑mesenchymal transition.

Authors:  Gang Yang; Guan Wang; Yongfu Xiong; Ji Sun; Weinan Li; Tao Tang; Jingdong Li
Journal:  Mol Med Rep       Date:  2021-04-28       Impact factor: 2.952

3.  Subtype-Based Prognostic Analysis of Cell-in-Cell Structures in Early Breast Cancer.

Authors:  Xin Zhang; Zubiao Niu; Hongquan Qin; Jie Fan; Manna Wang; Bo Zhang; You Zheng; Lihua Gao; Zhaolie Chen; Yanhong Tai; Mo Yang; Hongyan Huang; Qiang Sun
Journal:  Front Oncol       Date:  2019-09-20       Impact factor: 6.244

4.  Cell-in-cell phenomenon associates with aggressive characteristics and cancer-related mortality in early oral tongue cancer.

Authors:  Alhadi Almangush; Antti A Mäkitie; Jaana Hagström; Caj Haglund; Luiz Paulo Kowalski; Pentti Nieminen; Ricardo D Coletta; Tuula Salo; Ilmo Leivo
Journal:  BMC Cancer       Date:  2020-09-03       Impact factor: 4.430

5.  Increase in non-professional phagocytosis during the progression of cell cycle.

Authors:  Alexander Hofmann; Florian Putz; Maike Büttner-Herold; Markus Hecht; Rainer Fietkau; Luitpold V Distel
Journal:  PLoS One       Date:  2021-02-05       Impact factor: 3.240

6.  Connection Between CDC20 Expression and Hepatocellular Carcinoma Prognosis.

Authors:  Xianfeng Zhang; Xianjun Zhang; Xinguo Li; Hongbing Bao; Guang Li; Ning Li; Hengli Li; Jian Dou
Journal:  Med Sci Monit       Date:  2021-03-31

7.  Identification of the hub genes and prognostic indicators of gastric cancer and correlation of indicators with tumor-infiltrating immune cell levels.

Authors:  Yun Ji; Lu Gao; Can Zhang; Xu Sun; Liping Dai; Zhenyu Ji; Jianying Zhang; Zhida Zhang; Wei Cao; Yang Zhao; Liguo Zhang
Journal:  J Cancer       Date:  2021-05-13       Impact factor: 4.207

8.  Identification of novel hub genes associated with gastric cancer using integrated bioinformatics analysis.

Authors:  Xiao-Qing Lu; Jia-Qian Zhang; Sheng-Xiao Zhang; Jun Qiao; Meng-Ting Qiu; Xiang-Rong Liu; Xiao-Xia Chen; Chong Gao; Huan-Hu Zhang
Journal:  BMC Cancer       Date:  2021-06-14       Impact factor: 4.430

9.  Based on Integrated Bioinformatics Analysis Identification of Biomarkers in Hepatocellular Carcinoma Patients from Different Regions.

Authors:  Linxin Teng; Kaiyuan Wang; Yu Liu; Yanxia Ma; Weiping Chen; Lei Bi
Journal:  Biomed Res Int       Date:  2019-10-28       Impact factor: 3.411

10.  Identification of crucial genes associated with lung adenocarcinoma by bioinformatic analysis.

Authors:  Jing-Jing Dai; Wu-Bi Zhou; Bing Wang
Journal:  Medicine (Baltimore)       Date:  2020-10-30       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.